Iterum Therapeutics (ITRM)

[exwannabe]

Still waiting . . .

That is the problem.

ITRM has known for well over a year that there was a real possibility another P3 would be needed. And have known it as a fact for 7 months or so.

Yet, they have yet to be able to get the trial started.

They have cash to run into 2014. They previously stated that was enough to complete a new trial. But as every month goes by the prospects look dimmer.

A P3 in this space can be fairly quick. But still we are talking a couple years.

The market is seeing a company running out of time. And still waiting on a path forward.